Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Florence Pasquier, Sabine Khalife-Hachem & Jean-Baptiste Micol. (2018) ANTIBIOSTOP, for all?. Infectious Diseases 50:7, pages 550-553.
Read now
Read now
Lenaïg Le Clech, Jean-Philippe Talarmin, Marie-Anne Couturier, Jean-Christophe Ianotto, Christophe Nicol, Ronan Le Calloch, Stéphanie Dos Santos, Pascal Hutin, Didier Tandé, Virginie Cogulet, Christian Berthou & Gaëlle Guillerm. (2018) Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study. Infectious Diseases 50:7, pages 539-549.
Read now
Read now
Articles from other publishers (49)
Sarah Cherri, Diana MalaebLamis Shouman, Iqbal Fahs, Rabih Hallit, Souheil Hallit, Bassem Malaeb & Pascale Salameh. (2023) Assessment of Antimicrobial Utilization among Cancer Patients with
Febrile Neutropenia at the Lebanese Hospitals. Current Drug Safety 18:4, pages 496-503.
Crossref
Crossref
Masaki Takigawa, Hiroyuki Tanaka, Junichi Suwa, Tomoya Obara, Yohei Maeda, Mamoru Sato, Yoshitomo Shimazaki, Toshihisa Onoda, Akihito Ishigami & Toshihiro Ishii. (2023) Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia. Medicina 59:4, pages 758.
Crossref
Crossref
丽 徐. (2023) Risk Factors, Pathogenic Bacteria Species Characteristics and Control Status of Leukemia Concurrent Infection. Advances in Clinical Medicine 13:05, pages 8715-8721.
Crossref
Crossref
Abby Douglas, Karin Thursky & Monica Slavin. (2022) New approaches to management of fever and neutropenia in high-risk patients. Current Opinion in Infectious Diseases 35:6, pages 500-516.
Crossref
Crossref
J. R. de la Court, A. H. W. Bruns, A. H. E. Roukens, I. O. Baas, K. van Steeg, M. L. Toren-Wielema, M. Tersmette, N. M. A. Blijlevens, R. A. G. Huis in ’t Veld, T. F. W. Wolfs, W. J. E. Tissing, Y. Kyuchukova & J. Heijmans. (2022) The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer. Infectious Diseases and Therapy 11:6, pages 2063-2098.
Crossref
Crossref
Ranganathan N. Iyer. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
3
63
.
Trang D. Trinh, Luke Strnad, Lloyd Damon, John H. Dzundza, Larissa R. Graff, Laura M. Griffith, Alexandra Hilts-Horeczko, Rebecca Olin, Samantha Shenoy, Catherine DeVoe, Lusha Wang, Rosa Rodriguez-Monguio, Tina M. Gu, Scott R. Hampton, Brian Allan C. Macapinlac, Katherine Yang & Sarah B. Doernberg. (2021) Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. Infection Control & Hospital Epidemiology 42:9, pages 1090-1097.
Crossref
Crossref
Katerina Tori, Giannoula S. Tansarli, Diane M. Parente, Markos Kalligeros, Panayiotis D. Ziakas & Eleftherios Mylonakis. (2020) The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients. Medicine 99:20, pages e20022.
Crossref
Crossref
Clyde D. Ford, Jana Coombs, Michaela Gazdik Stofer, Bert K. Lopansri, Brandon J. Webb, Fabiana Ostronoff, Julie Asch & Daanish Hoda. (2019)
Decrease in vancomycin-resistant
Enterococcus
colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia
. Infection Control & Hospital Epidemiology 40:7, pages 774-779.
Crossref
Crossref
Firdevs Aksoy & Iftihar Koksal. (2019) Evaluation of oropharyngeal infections in febrile neutropenic patients: a study of 335 episodes. Mucosa, pages 41-47.
Crossref
Crossref
Zoé Van de Wyngaert, Céline Berthon, Houria Debarri, Claire Bories, Sarah Bonnet, Morgane Nudel, Benjamin Carpentier, Charline Legrand, Sarah Barbieux, Paul Chauvet, Arthur Simonnet, Alexandre Willaume, Jean-Baptiste Bossard, Loic Renaud, Kevin James Wattebled, Guillaume Escure, Nicolas Branche, Ines Arib, Marie Titecat, Bruno Quesnel & Serge Alfandari. (2019) Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort. International Journal of Antimicrobial Agents 53:6, pages 781-788.
Crossref
Crossref
Rodolfo Rivas-Ruiz, Miguel Villasis-Keever, Guadalupe Miranda-Novales, Osvaldo D Castelán-Martínez & Silvia Rivas-Contreras. (2019) Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. Cochrane Database of Systematic Reviews 2019:4.
Crossref
Crossref
Anat Stern, Elena Carrara, Roni Bitterman, Dafna Yahav, Leonard Leibovici & Mical Paul. (2019) Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer. Cochrane Database of Systematic Reviews 2019:1.
Crossref
Crossref
Marie Shimanuki, Yorihisa Imanishi, Yoichiro Sato, Nana Nakahara, Daisuke Totsuka, Emiri Sato, Sena Iguchi, Yasuo Sato, Keiko Soma, Yasutomo Araki, Seiji Shigetomi, Satoko Yoshida, Kosuke Uno, Yusuke Ogawa, Takehiro Tominaga, Yuichi Ikari, Junko Nagayama, Ayako Endo, Koshiro Miura, Takuya Tomioka, Hiroyuki Ozawa & Kaoru Ogawa. (2018) Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma. Oncotarget 9:27, pages 18970-18984.
Crossref
Crossref
Manuela Aguilar-Guisado, Ildefonso Espigado, Almudena Martín-Peña, Carlota Gudiol, Cristina Royo-Cebrecos, José Falantes, Lourdes Vázquez-López, María Isabel Montero, Clara Rosso-Fernández, María de la Luz Martino, Rocío Parody, José González-Campos, Sebastián Garzón-López, Cristina Calderón-Cabrera, Pere Barba, Nancy Rodríguez, Montserrat Rovira, Enrique Montero-Mateos, Jordi Carratalá, José Antonio Pérez-Simón & José Miguel Cisneros. (2017) Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. The Lancet Haematology 4:12, pages e573-e583.
Crossref
Crossref
Matthew Snyder, Yanina Pasikhova & Aliyah Baluch. (2017) Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review. Open Forum Infectious Diseases 4:4.
Crossref
Crossref
Yusuke Moriyama, Nobuyuki Horita, Makoto Kudo, Masaharu Shinkai, Hiroyuki Fujita, Takeharu Yamanaka, Yoshiaki Ishigatsubo & Takeshi Kaneko. (2015) Monocyte nadir is a possible indicator for neutrophil nadir during lung cancer chemotherapy. The Clinical Respiratory Journal 11:4, pages 453-458.
Crossref
Crossref
Nikolaos Andreatos, Myrto Eleni Flokas, Anna Apostolopoulou, Michail Alevizakos & Eleftherios Mylonakis. (2017) The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases 4:3.
Crossref
Crossref
C. Wintenberger, B. Guery, E. Bonnet, B. Castan, R. Cohen, S. Diamantis, P. Lesprit, L. Maulin, Y. Péan, E. Peju, L. Piroth, J.P. Stahl, C. Strady, E. Varon, F. Vuotto & R. Gauzit. (2017) Proposal for shorter antibiotic therapies. Médecine et Maladies Infectieuses 47:2, pages 92-141.
Crossref
Crossref
Konstantinos Z. Vardakas, Kyriakos K. Trigkidis, Eleni Boukouvala & Matthew E. Falagas. (2016) Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. International Journal of Antimicrobial Agents 48:1, pages 1-10.
Crossref
Crossref
Helen L. Leather & John R. Wingard. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
1038
1062
.
J.-B. Micol, C. Chahine, P.-L. Woerther, D. Ghez, F. Netzer, C. Dufour, M. Merad, F. Blot, E. Chachaty, S. de Botton & B. Gachot. (2014) Discontinuation of empirical antibiotic therapy in neutropenic acute myeloid leukaemia patients with fever of unknown origin: is it ethical?. Clinical Microbiology and Infection 20:7, pages O453-O455.
Crossref
Crossref
B.J. McCullough, L.E. Wiggins, A. Richards, K. Klinker, J.W. Hiemenz & J.R. Wingard. (2014) Aztreonam for febrile neutropenia in patients with beta-lactam allergy. Transplant Infectious Disease 16:1, pages 145-152.
Crossref
Crossref
Charulata Ramaprasad & Kenneth J. Pursell. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients
351
370
.
Reineke A Schoot, Elvira C van Dalen, Cornelia H van Ommen & Marianne D van de Wetering. (2013) Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Frank P. Tverdek, Kenneth V. RolstonRoy F. Chemaly. (2012) Antimicrobial Stewardship in Patients with Cancer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:8, pages 722-734.
Crossref
Crossref
Christian Kjellander, Magnus Björkholm, Honar Cherif, Mats Kalin & Christian G. Giske. (2012) Hematological: Low all‐cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single‐center study. European Journal of Haematology 88:5, pages 422-430.
Crossref
Crossref
F. Weissinger & W. J. Heinz. (2012) Prevention and treatment of febrile neutropenia. memo - Magazine of European Medical Oncology 5:1, pages 30-34.
Crossref
Crossref
Anat Gafter-Gvili, Abigail Fraser, Mical Paul, Liat Vidal, Theresa A Lawrie, Marianne D van de Wetering, Leontien CM Kremer & Leonard Leibovici. (2012) Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database of Systematic Reviews 2018:7.
Crossref
Crossref
Mizuho Ichikawa, Daisuke Suzuki, Junjiro Ohshima, Yuko Cho, Makoto Kaneda, Akihiro Iguchi & Tadashi Ariga. (2011) Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia. Pediatric Blood & Cancer 57:7, pages 1159-1162.
Crossref
Crossref
Mical Paul, Dafna Yahav, Assaf Bivas, Abigail Fraser & Leonard Leibovici. (2011) Cochrane Review: Anti‐pseudomonal beta‐lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta‐lactams. Evidence-Based Child Health: A Cochrane Review Journal 6:6, pages 2026-2185.
Crossref
Crossref
Thomas M. File. (2011) Highlights From Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients With Cancer. Infectious Diseases in Clinical Practice 19:5, pages 352-353.
Crossref
Crossref
Rodolfo Rivas-Ruiz, Miguel Villasis-Keever & Maria G Miranda-Novales. (2011) Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic event. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young & John R. Wingard. (2011) Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 52:4, pages e56-e93.
Crossref
Crossref
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young & John R. Wingard. (2011) Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 52:4, pages 427-431.
Crossref
Crossref
Mical Paul, Dafna Yahav, Assaf Bivas, Abigail Fraser & Leonard Leibovici. (2010) Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database of Systematic Reviews 2015:2.
Crossref
Crossref
Sema Vural, Ela Erdem, Seda Geylani Gulec, Yildiz Yildirmak & Rejin Kebudi. (2010) Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia. Pediatrics International 52:2, pages 262-267.
Crossref
Crossref
L. Gómez, C. Estrada, I. Gómez, M. Márquez, C. Estany, J. M. Martí, R. Bastús, L. Cirera, S. Quintana & J. Garau. (2010) Low-dose β-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial. European Journal of Clinical Microbiology & Infectious Diseases 29:4, pages 417-427.
Crossref
Crossref
Masaki Fujita, Hiroshi Ouchi, Tsukasa Ohshima, Yuichi Inoue, Ichiro Inoshima, Yoichi Nakanishi, Chikara Yoshimura, Hiroshi Wataya, Masayuki Kawasaki & Shoji Tokunaga. (2010) Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer. Journal of Infection and Chemotherapy 16:2, pages 113-117.
Crossref
Crossref
Trent G Towne, James S Lewis & Kelly Echevarria. (2009) Efficacy and safety of cefepime. The Lancet Infectious Diseases 9:1, pages 4-6.
Crossref
Crossref
. 2009. Emerging Issues and Controversies in Infectious Disease. Emerging Issues and Controversies in Infectious Disease
165
188
.
Tomonobu Sato, Ryoji Kobayashi, Kazue Yasuda, Makoto Kaneda, Akihiro Iguchi & Kunihiko Kobayashi. (2008) A prospective, randomized study comparing cefozopran with piperacillin–tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Pediatric Blood & Cancer 51:6, pages 774-777.
Crossref
Crossref
S. J. Edwards, M. J. Clarke, S. Wordsworth & C. E. Emmas. (2008) Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials. European Journal of Clinical Microbiology & Infectious Diseases 27:7, pages 531-543.
Crossref
Crossref
Nabil Ahmed, Hadir A. El‐Mahallawy, Ibrahim A. Ahmed, Shimaa Nassif, Aamal El‐Beshlawy & Alaa El‐Haddad. (2007) Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. Pediatric Blood & Cancer 49:6, pages 786-792.
Crossref
Crossref
Zeina A. Kanafani, Ghenwa K. Dakdouki, Khalil I. El-Chammas, Shaker Eid, George F. Araj & Souha S. Kanj. (2007) Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade. International Journal of Infectious Diseases 11:5, pages 450-453.
Crossref
Crossref
Dafna Yahav, Mical Paul, Abigail Fraser, Nadav Sarid & Leonard Leibovici. (2007) Efficacy and safety of cefepime: a systematic review and meta-analysis. The Lancet Infectious Diseases 7:5, pages 338-348.
Crossref
Crossref
Mical Paul, Dafna Yahav, Abigail Fraser & Leonard Leibovici. (2006) Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy 57:2, pages 176-189.
Crossref
Crossref
Isidro Jarque, Miguel Salavert & Miguel A. Sanz. (2005) Manejo del paciente neutropénico con fiebre. Enfermedades Infecciosas y Microbiología Clínica 23, pages 24-29.
Crossref
Crossref
Anat Gafter-Gvili, Abigail Fraser, Mical Paul, Marianne D van de Wetering, Leontien CM Kremer & Leonard Leibovici. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.